Entries by numaferm-admin

TIDES 2018, Boston

NUMAFERM’s CEO Dr. Christian Schwarz is going to take part in the 2018 TIDES Convention, that takes place in Boston in May. TIDES is the largest meeting to accelerate peptide products from early discovery to late-stage development & commercialization. Please get in contact with Christian (christian.schwarz@numaferm.com) in order to pre-arrange one-on-one meetings. We are looking […]

Evonik is investing in NUMAFERM

Through its Venture Capital unit, Evonik has invested in the start-up NUMAFERM and now holds a minority share in the biotechnology company, which is located in Düsseldorf. The investment was made as part of a seed financing round and also includes investments by High-Tech Gründerfonds, the Business Angels and Qiagen co-founders Detlev Riesner and Jürgen […]

Minister Pinkwart visits NUMAFERM

Prof. Dr. Andreas Pinkwart, NRW Minister for Economy and Digitization, has visited NUMAFERM as part of “Neue Gründerzeit NRW” on August 17. Pinkwart was given an introduction to the innovative production technology of NUMAFERM that perfectly fits to the idea of bioeconomy. The company, investors, Pinkwart and further participants talked about the importance of life-sciences […]

NUMAFERM closes Seed-Round

The Dusseldorf university spin-off NUMAFERM specializes in the biotechnical production of peptides and is able, through its newly developed platform technology, to dramatically reduce costs for this raw material. For the further technological development and an accelerated market entry, NUMAFERM GmbH is now receiving funding in the seven-digit range. High-Tech Gründerfonds (HTGF), Qiagen co-founders and […]